Psychedelic Science 2023
Psychedelic Science 2023

Speakers

Psychedelic Science 2023 will feature over 350 speakers from across the world across presenting on nine stages at the Colorado Convention Center, making this the largest psychedelic education opportunity in history.

The conference speaker program will cover science and medicine, as well as the whole world of important themes and topics related to psychedelics.

Our first set of speakers have just been released, with more announcements to come throughout the year. (You can see our statement on diversity in the PS2023 line-up here.)

Rick Doblin

Founder and Executive Director, MAPS

Rachel Aidan

CEO / Synthesis Institute

Brian Anderson, MD, MSc

Assistant Clinical Professor, Dept. Psychiatry And Behavioral Sciences / UCSF

Matthew Baggott, PhD

Co-Founder & CEO / Tactogen

Frederick Barrett, PhD

Associate Director, Center For Psychedelic And Consciousness Research / Johns Hopkins University School of Medicine

Anthony P. Bossis, PhD

Clinical Assistant Professor Of Psychiatry / NYU Grossman School of Medicine; NYU Center for Psychedelic Medicine

Graham Boyd

Co-Founder & Executive Director / Psychedelic Science Funders Collaborative

Robin Carhart-Harris, PhD

Ralph Metzner Distinguished Professor Of Neurology, Psychiatry And Behavioral Sciences / University Of California San Francisco

Terence Ching, PhD

Postdoctoral Associate / Yale OCD Research Clinic

Mary P. Cosimano, LMSW

Director Of Guide Services / Johns Hopkins University, Center For Psychedelic And Consciousness Research

Elias Dakwar, MD

Associate Professor Of Clinical Psychiatry / Columbia University School Of Medicine

Corine De Boer, MD, PhD

Chief Medical Officer / MAPS Public Benefit Corporation

Benjamin De Loenen

Founder & Executive Director / International Center For Ethnobotanical Education Research & Service (ICEERS)

Christina Dent

Founder & President / End It For Good

Harriet De Wit, PhD

Professor Of Psychiatry & Behavioral Neuroscience / University Of Chicago

Gül Dölen, MD/PhD

Principal Investigator, Dölen Lab, Department Of Neuroscience / Johns Hopkins University School Of Medicine

Manoj Doss

Postdoctoral Scholar / Johns Hopkins University School Of Medicine

Tom Eckert, MS

Founder / InnerTrek And The Sheri Eckert Foundation

James Fadiman, PhD

Independent Researcher

Cosmo Feilding Mellen

CEO / Beckley Psytech

Rock Feilding-Mellen

Co-Founder / Beckley Waves, Beckley Retreats, And Beckley Academy

Sara Gael

Harm Reduction Officer; Sub-Investigator, MAPS MDMA Assisted Therapy Clinical Trials / MAPS

Albert Garcia-Romeu, PhD

Assistant Professor Of Psychiatry And Behavioral Sciences / Johns Hopkins University School Of Medicine

Mitchell Gomez

Executive Director / DanceSafe

Joe Green

President And Co-Founder / The Psychedelic Science Funders Collaborative (PSFC)

George Greer, MD

Board Chair / Heffter Research Institute

Roland Griffiths, PhD

Founding Director, Center For Psychedelic And Consciousness Research, Departments Of Psychiatry And Neuroscience / Johns Hopkins University School Of Medicine

Natalie Gukasyan, MD

Assistant Professor, Department Of Psychiatry And Behavioral Sciences Medical Director, Center For Psychedelic And Consciousness / Johns Hopkins University School Of Medicine

Carl Hart, PhD

Ziff Professor Of Psychology (In Psychiatry) / Columbia University

Danielle M. Herrera, MA, LMFT

Harm Reduction & Psychedelic Psychotherapist / Sage Integrative Health

Julie Holland, MD

Psychiatrist And Author / MAPS

Steven Huang

Justice Equity Diversity Inclusion (JEDI) Officer / MAPS

Ayize Jama-Everett, MDiv, MA, MFA

A Table Of Our Own

Robert Jesse

Researcher & Advisor

Matthew W. Johnson, PhD

Susan Hill Ward Professor Of Psychedelics & Consciousness Research / Johns Hopkins University School Of Medicine

Jeffrey D. Kamlet, MD

Chief Medical Officer / Beond

Daniel F. Kelly, MD

Director & Co-Founder / Pacific Neuroscience Institute

Dr. Rachel Knox, MD, MBA

Co-Founder And President, Cannabis Health Equity Movement / Co-Founder, Pivital Holdings

Robert L. Koffman, MD, MPH

Psychiatrist, Sunstone Therapies / Board Of Psychedelic Medicine And Therapies, Chair (BPMT)

Dr. Kim PC Kuypers, PhD

Associate Professor / Maastricht University

Bia Labate, PhD

Public Education And Culture Specialist, MAPS/ Chacruna Institute/ CIIS

Ronan Levy

CEO / Field Trip Health & Wellness Ltd.

Candace R. Lewis, MC, PhD

Assistant Professor / University Of Arizona College Of Medicine – Phoenix

Bill Linton

Bill Linton

Executive Director / Usona Institute

Bill Linton

Executive Director / Usona Institute

Dr. Larissa Maier, PhD

Dr. Larissa Maier, PhD

Global Drug Survey

Dr. Larissa Maier, PhD

Global Drug Survey

 Murtaza Majeed

Murtaza Majeed

Center of Excellence

Murtaza Majeed

Center Of Excellence

Dr. David Mathai, MD

Dr. David Mathai, MD

Postdoctoral Research Fellow and Assistant Faculty / Johns Hopkins University School of Medicine

Dr. David Mathai, MD

Postdoctoral Research Fellow And Assistant Faculty / Johns Hopkins University School Of Medicine

Dennis J. McKenna, PhD

Dennis J. McKenna, PhD

President and Principal Founder / McKenna Academy of Natural Philosophy

Dennis J. McKenna, PhD

President And Principal Founder / McKenna Academy Of Natural Philosophy

Sandeep Nayak, MD

Sandeep Nayak, MD

Assistant Professor / Johns Hopkins Center for Psychedelic and Consciousness Research

Sandeep Nayak, MD

Assistant Professor / Johns Hopkins Center For Psychedelic And Consciousness Research

David Nutt

David Nutt

Professor of Neuropsychopharmacology and Head of the Centre for Psychedelic Research / Imperial College London

David Nutt

Professor Of Neuropsychopharmacology And Head Of The Centre For Psychedelic Research / Imperial College London

Payton Nyquvest

Payton Nyquvest

Founder, Chair & CEO / Numinus Wellness Inc.

Payton Nyquvest

Founder, Chair & CEO / Numinus Wellness Inc.

Anny Ortiz

Anny Ortiz

PhD Candidate / The School of Human Ecology, UW-Madison

Anny Ortiz

PhD Candidate / The School Of Human Ecology, UW-Madison

Jason Ortiz

Jason Ortiz

Executive Director / SSDP

Jason Ortiz

Executive Director / SSDP

Janis Phelps, PhD

Janis Phelps, PhD

Professor, Founder and Director / CIIS Center for Psychedelic Therapies and Research

Janis Phelps, PhD

Professor, Founder And Director / CIIS Center For Psychedelic Therapies And Research

Katrin Preller, PhD

Katrin Preller, PhD

Research Group Lead / Psychiatric University Hospital Zurich

Katrin Preller, PhD

Research Group Lead / Psychiatric University Hospital Zurich

Sara Reed, MS, LMFT

Sara Reed, MS, LMFT

Creative Executive / Minds iHealth Solutions, Inc.

Sara Reed, MS, LMFT

Creative Executive / Minds IHealth Solutions, Inc.

Favianna Rodriguez

Favianna Rodriguez

President / The Center for Cultural Power

Favianna Rodriguez

President / The Center For Cultural Power

Leor Roseman

Leor Roseman

Postdoc / Centre for Psychedelic Research, Imperial College London

Leor Roseman

Postdoc / Centre For Psychedelic Research, Imperial College London

Stephen Ross, MD

Stephen Ross, MD

Research Associate Professor of Psychiatry and Child & Adolescent Psychiatry Associate Director / NYU Langone Health

Stephen Ross, MD

Research Associate Professor Of Psychiatry And Child & Adolescent Psychiatry Associate Director / NYU Langone Health

Barbara Olasov Rothbaum, PhD

Barbara Olasov Rothbaum, PhD

Director, Emory Healthcare Veterans Program, Paul A. Janssen Chair in Neuropsychopharmacology / Emory University School of Medicine

Barbara Olasov Rothbaum, PhD

Director, Emory Healthcare Veterans Program, Paul A. Janssen Chair In Neuropsychopharmacology / Emory University School Of Medicine

Adam Safron

Adam Safron

Postdoctoral Research Fellow / Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine

Adam Safron

Postdoctoral Research Fellow / Center For Psychedelic And Consciousness Research, Johns Hopkins University School Of Medicine

Ceyda Sayali, PhD

Ceyda Sayali, PhD

Postdoctoral Fellow / Johns Hopkins University, Center for Psychedelic and Consciousness Research

Ceyda Sayali, PhD

Postdoctoral Fellow / Johns Hopkins University, Center For Psychedelic And Consciousness Research

Eduardo Schenberg, PhD

Eduardo Schenberg, PhD

Founder and Managing Director / Instituto Phaneros

Eduardo Schenberg, PhD

Founder And Managing Director / Instituto Phaneros

Nathan Sepeda

Nathan Sepeda

Research Data Specialist / Johns Hopkins Center for Psychedelic and Consciousness Research

Nathan Sepeda

PResearch Data Specialist / Johns Hopkins Center For Psychedelic And Consciousness Research

Dr. Ben Sessa

Dr. Ben Sessa

Chief Medical Officer / Awakn Life Sciences

Dr. Ben Sessa

Chief Medical Officer / Awakn Life Sciences

Paul Stamets

Paul Stamets

Myconaut, Earthling

Paul Stamets

Myconaut, Earthling

Justin Strickland

Justin Strickland

Assistant Professor / Johns Hopkins University School of Medicine

Justin Strickland

Assistant Professor / Johns Hopkins University School Of Medicine

Chris Timmermann, PhD

Chris Timmermann, PhD

Imperial College London and EcoH Foundation

Chris Timmermann, PhD

Imperial College London And EcoH Foundation

Kathryn Tucker, JD

Kathryn Tucker, JD

Special Counsel and Co-Chair Psychedelics Practice Group
Emerge Law Group

Kathryn Tucker, JD

Special Counsel And Co-Chair Psychedelics Practice Group
Emerge Law Group

Eric Vermetten, MD, PhD

Eric Vermetten, MD, PhD

Professor Psychiatry / Leiden University Medical Center

Eric Vermetten, MD, PhD

Professor Psychiatry / Leiden University Medical Center

David B. Yaden, PhD

David B. Yaden, PhD

Assistant Professor, Center for Psychedelic and Consciousness Research / Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine

David B. Yaden, PhD

Assistant Professor, Center For Psychedelic And Consciousness Research / Behavioral Pharmacology Research Unit, Department Of Psychiatry And Behavioral Sciences, Johns Hopkins University School Of Medicine

Berra Yazar-Klosinski, PhD

Berra Yazar-Klosinski, PhD

Chief Scientific Officer / MAPS Public Benefit Corporation

Berra Yazar-Klosinski, PhD

Chief Scientific Officer / MAPS Public Benefit Corporation